Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin | 8 | 2018 | 113 | 0.920 |
Why?
|
| Skin Neoplasms | 4 | 2022 | 60 | 0.770 |
Why?
|
| Arthritis, Gouty | 1 | 2020 | 1 | 0.640 |
Why?
|
| Panniculitis | 1 | 2020 | 5 | 0.640 |
Why?
|
| Hemangioma | 2 | 2019 | 8 | 0.600 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2019 | 4 | 0.580 |
Why?
|
| Skin Diseases, Vascular | 3 | 2018 | 3 | 0.570 |
Why?
|
| Blastomyces | 1 | 2018 | 11 | 0.560 |
Why?
|
| Blastomycosis | 1 | 2018 | 20 | 0.550 |
Why?
|
| Pyoderma Gangrenosum | 2 | 2007 | 2 | 0.490 |
Why?
|
| Vasculitis | 2 | 2018 | 25 | 0.370 |
Why?
|
| Sweet Syndrome | 2 | 2006 | 2 | 0.340 |
Why?
|
| Amyloidosis | 1 | 2010 | 11 | 0.320 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 17 | 0.310 |
Why?
|
| Skin Diseases | 1 | 2010 | 15 | 0.310 |
Why?
|
| Lipectomy | 1 | 2009 | 1 | 0.300 |
Why?
|
| Back | 1 | 2009 | 2 | 0.300 |
Why?
|
| Lipomatosis | 1 | 2009 | 3 | 0.300 |
Why?
|
| Abdomen | 1 | 2009 | 7 | 0.300 |
Why?
|
| Extremities | 1 | 2009 | 24 | 0.290 |
Why?
|
| Dapsone | 1 | 2008 | 1 | 0.290 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2008 | 1 | 0.290 |
Why?
|
| Dermatologic Agents | 1 | 2008 | 4 | 0.290 |
Why?
|
| Acne Vulgaris | 1 | 2008 | 3 | 0.290 |
Why?
|
| Anemia, Hemolytic | 1 | 2008 | 4 | 0.290 |
Why?
|
| Humans | 20 | 2022 | 23495 | 0.280 |
Why?
|
| Drug Eruptions | 2 | 2007 | 8 | 0.280 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2008 | 3 | 0.270 |
Why?
|
| Male | 13 | 2022 | 12823 | 0.260 |
Why?
|
| Pseudolymphoma | 1 | 2007 | 1 | 0.260 |
Why?
|
| Lymphoma | 1 | 2007 | 33 | 0.250 |
Why?
|
| Hand Dermatoses | 1 | 2006 | 1 | 0.240 |
Why?
|
| Adult | 7 | 2022 | 7090 | 0.220 |
Why?
|
| Mycosis Fungoides | 2 | 2022 | 5 | 0.210 |
Why?
|
| Middle Aged | 8 | 2022 | 8096 | 0.190 |
Why?
|
| Photochemotherapy | 1 | 2022 | 2 | 0.190 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2022 | 4 | 0.190 |
Why?
|
| Facial Dermatoses | 1 | 2000 | 1 | 0.160 |
Why?
|
| Platelet Aggregation | 1 | 2000 | 6 | 0.160 |
Why?
|
| Myeloproliferative Disorders | 1 | 2000 | 4 | 0.160 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2000 | 3 | 0.160 |
Why?
|
| Thrombophilia | 1 | 2000 | 6 | 0.160 |
Why?
|
| Thorax | 1 | 2019 | 7 | 0.150 |
Why?
|
| Female | 8 | 2022 | 13305 | 0.140 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 309 | 0.110 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1994 | 5 | 0.100 |
Why?
|
| Tretinoin | 1 | 1994 | 14 | 0.100 |
Why?
|
| Adolescent | 2 | 2009 | 1911 | 0.100 |
Why?
|
| Candidiasis, Cutaneous | 1 | 2010 | 1 | 0.080 |
Why?
|
| Neutrophils | 2 | 2006 | 89 | 0.080 |
Why?
|
| Biopsy | 3 | 2006 | 184 | 0.080 |
Why?
|
| Hyperplasia | 1 | 2009 | 19 | 0.070 |
Why?
|
| Syndrome | 1 | 2009 | 67 | 0.070 |
Why?
|
| Immunoglobulin A | 1 | 1989 | 12 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2008 | 27 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 64 | 0.070 |
Why?
|
| Aged | 4 | 2010 | 7709 | 0.070 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2008 | 19 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2008 | 374 | 0.070 |
Why?
|
| Leg | 1 | 2007 | 41 | 0.060 |
Why?
|
| Prednisone | 1 | 2007 | 63 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 67 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2006 | 59 | 0.060 |
Why?
|
| Child | 1 | 2008 | 1164 | 0.060 |
Why?
|
| Young Adult | 1 | 2008 | 1724 | 0.050 |
Why?
|
| Ointments | 1 | 2022 | 1 | 0.050 |
Why?
|
| Perylene | 1 | 2022 | 1 | 0.050 |
Why?
|
| Anthracenes | 1 | 2022 | 4 | 0.050 |
Why?
|
| Photosensitizing Agents | 1 | 2022 | 4 | 0.050 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2000 | 1 | 0.040 |
Why?
|
| Capillaries | 1 | 2000 | 10 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2000 | 63 | 0.040 |
Why?
|
| Dermatology | 1 | 1998 | 5 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2018 | 28 | 0.030 |
Why?
|
| Consensus | 1 | 2018 | 82 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 3058 | 0.030 |
Why?
|
| Leukemic Infiltration | 1 | 1994 | 1 | 0.030 |
Why?
|
| Lipoma | 1 | 1991 | 4 | 0.020 |
Why?
|
| Bromocriptine | 1 | 1989 | 3 | 0.020 |
Why?
|
| Scleroderma, Localized | 1 | 1989 | 3 | 0.020 |
Why?
|
| Necrosis | 1 | 1989 | 22 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1989 | 52 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 540 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1989 | 95 | 0.020 |
Why?
|
| Forecasting | 1 | 1998 | 80 | 0.010 |
Why?
|
| Giant Cells | 1 | 1992 | 2 | 0.010 |
Why?
|
| Epidermis | 1 | 1992 | 2 | 0.010 |
Why?
|
| Histiocytes | 1 | 1992 | 4 | 0.010 |
Why?
|
| Granuloma | 1 | 1992 | 12 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1992 | 70 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1992 | 51 | 0.010 |
Why?
|
| Eosinophils | 1 | 1992 | 36 | 0.010 |
Why?
|
| Factor VIIIa | 1 | 1991 | 1 | 0.010 |
Why?
|
| Desmin | 1 | 1991 | 2 | 0.010 |
Why?
|
| S100 Proteins | 1 | 1991 | 4 | 0.010 |
Why?
|
| Ear, External | 1 | 1991 | 2 | 0.010 |
Why?
|
| Myoglobin | 1 | 1991 | 2 | 0.010 |
Why?
|
| Ear Neoplasms | 1 | 1991 | 5 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1991 | 340 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 1989 | 3 | 0.000 |
Why?
|